709 filings
Page 6 of 36
S-1MEF
meid1x3j4 900eb
13 Jan 21
Registration of additional securities for an S-1
8:15pm
CORRESP
kfgs 9351xtc4ic94lg3
13 Jan 21
Correspondence with SEC
12:00am
CORRESP
xitqs
13 Jan 21
Correspondence with SEC
12:00am
FWP
ewy39zz
4 Jan 21
Free writing prospectus
6:31am
UPLOAD
8epre2
22 Dec 20
Letter from SEC
12:00am
8-K
5www6vhd3kr71 ki6
17 Dec 20
Material Modifications to Rights of Security Holders
8:29am
8-K
zp5r7ocoupz03zjb2zk
10 Dec 20
Viveve Announces FDA Approval of Proposed Amendments to Pivotal U.S. PURSUIT Trial Protocol
8:29am
8-K
7a8nfd2t7 m8
3 Dec 20
Viveve Announces FDA 510K Approval to Expand Manufacturing of Treatment Tips
8:29am
8-K
ss1wopyyrnbac zhlo
1 Dec 20
Material Modifications to Rights of Security Holders
8:15am
8-K
2zz3c7pkx74l
12 Nov 20
Viveve Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:04pm
8-K
fgc isodim7fxnn
10 Nov 20
Viveve to Participate in Alliance Group Partners Virtual Healthcare Symposium
8:29am
8-K
uc7y5 4ypzo3
30 Oct 20
Viveve Appoints New Independent Board Director
8:36am
8-K
lfbo 02ta
27 Oct 20
Viveve Launches New Clinical Advisory Board in Urinary Incontinence
8:29am
8-K
3jmpj
22 Sep 20
Viveve Announces Issuance of Novel U.S. Method Patent for Stress Urinary Incontinence
8:29am
8-K
dbxxd nc4
3 Sep 20
Viveve to Present at H.C. Wainwright 22nd Annual Global Investment Conference
8:29am